|
CARD and Lineagen Offer Genetic Testing, Counseling for Children on Autism Spectrum
Posted on:
December 17, 2012
Center for Autism and Related Disorders (CARD) and Lineagen Inc. launched a new clinical partnership this month to offer Lineagen's FirstStep(Dx) genetic test to patients and their families. FirstStep(Dx) is a whole-genome genetic test customized with validated, novel proprietary genetic variants associated with ASDs. Under the terms of the partnership agreement, FirstStep(Dx), integrated with a pre-and post-test genetic counseling service and personalized reporting, will be offered to patients receiving treatment in CARD's innovative Skills® program. The program is the first of its kind, designed to fully meet current clinical guidelines that recommend chromosomal microarray analysis as a first-line genetic test as part of a comprehensive diagnostic evaluation of individuals with ASDs.
CARD is the world's largest provider of state-of-the-art, early intensive behavioral intervention for individuals with ASDs. Lineagen is an innovative molecular diagnostics company focused on integrated genetic testing and counseling for individuals with ASDs and other disorders of childhood development.
www.lineagen.com.
|
|
News Watch Archives |
|
|
|